DISCLOSURES: Dr. Evans has received research funding from Hologic, Inc for the evaluation of tomosynthesis technology.
1542-4863/asset/CAAC_left.gif?v=1&s=b30825cac69353e6291703284644f96de5014146)
1542-4863/asset/olbannerright.gif?v=1&s=c4e79cd950d71afe81f443027d81136e7d370bd2)
Editorial
You have free access to this content
Breast cancer screening: Successes and challenges†
Article first published online: 15 NOV 2011
DOI: 10.3322/caac.20137
Copyright © 2011 American Cancer Society, Inc.
Additional Information
How to Cite
Evans, W. P. (2012), Breast cancer screening: Successes and challenges. CA: A Cancer Journal for Clinicians, 62: 5–9. doi: 10.3322/caac.20137
- †
Publication History
- Issue published online: 11 JAN 2012
- Article first published online: 15 NOV 2011
References
- 1Altekruse SF, Kosary CL, Krapcho M, et al, eds. Surveillance, Epidemiology, and End Results Cancer Statistics Review, 1975-2007. Bethesda, MD: National Cancer Institute; 2010. Available at: http://seer.cancer.gov/csr/1975_2007/, based on November 2009 SEER data submission, posted to the SEER Web site, 2010.
- 2, , . Declining death rates reflect progress against cancer. PLoS One. 2010; 5: e9584.
- 3, , , et al; Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005; 353: 1784-1792.
- 4, , , et al. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer. 2002; 95: 458-469.
- 5Swedish Organised Service Screening Evaluation Group. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data. Cancer Epidemiol Biomarkers Prev. 2006; 15: 45-51.
- 6, , , , , . Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer. 2001; 91: 1724-1731.
- 7, , , et al. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort. Cancer. 2011; 117: 714-722.
- 8, , , et al. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet. 2003; 361: 1411-1417.
- 9
- 10, , , , . Survival experience in the Breast Cancer Detection Demonstration Project. CA Cancer J Clin. 1987; 37: 258-290.
- 11, , , . Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years [erratum, Can Med Assoc J. 1993; 148: 718]. CMAJ. 1992; 147: 1459-1476.
- 12, . Randomization in the Canadian National Breast Screening Study: a review for evidence of subversion. CMAJ. 1997; 156: 193-199.
- 13, , , . Breast cancer mortality after screening mammography in British Columbia women. Int J Cancer. 2007; 120: 1076-1080.
- 14, , , , , . Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet. 2003; 361: 1405-1410.
- 15, , , , , ; U.S. Preventive Services Task Force. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2009; 151: 727-737.
- 16, , , et al. Performance benchmarks for screening mammography. Radiology. 2006; 241: 55-66.
- 17, . United States Preventive Services Task Force screening mammography recommendations: science ignored. AJR Am J Roentgenol. 2011; 196: W112-W116.
- 18, . Clinical practice. Mammographic screening for breast cancer. N Engl J Med. 2003; 348: 1672-1680.
- 19NIH Consensus Statement. Breast cancer screening for women ages 40-49. NIH Consens Statement. 1997; 15: 1-35.
- 20, . Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ. 2009; 339: b2587.
- 21, , , , . Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study. BMJ. 2006; 332: 689-692.
- 22, , , et al. Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer. Breast Cancer Res. 2005; 7: 258-265.
- 23, , , , . Overdiagnosis, sojourn time, and sensitivity in the Copenhagen mammography screening program. Breast J. 2006; 12: 338-342.
- 24, , , , , . An estimate of overdiagnosis 15 years after the start of mammographic screening in Florence. Eur J Cancer. 2009; 45: 3166-3171.
- 25, , , et al. The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. Radiol Clin North Am. 2000; 38: 625-651.
- 26, , , et al; ACRIN 6666 Investigators. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA. 2008; 299: 2151-2163.
- 27. Tailored supplemental screening for breast cancer: what now and what next? AJR Am J Roentgenol. 2009; 192: 390-399.
- 28, , . Performance and reporting of clinical breast examination: a review of the literature. CA Cancer J Clin. 2004; 54: 345-361.
- 29, , , , , . Cancer screening in the United States, 2011: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2011; 61: 8-30.
- 30; Canadian Task Force on Preventive Health Care. Preventive health care, 2001 update: should women be routinely taught breast self-examination to screen for breast cancer? CMAJ. 2001; 164: 1837-1846.
- 31, , , et al. Reported drop in mammography: is this cause for concern? Cancer. 2007; 109: 2405-2409.
- 32, , , et al. Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med. 2006; 144: 541-553.
- 33, , , , , . Parity and disparity in first course treatment of invasive breast cancer. Breast Cancer Res Treat. 2008; 109: 545-557.